Cybin Competitors

Cybin (OTCMKTS:CLXPF) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Cybin and (DDXS), as provided by MarketBeat.com.

Profitability

This table compares Cybin and (DDXS)'s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Cybin and (DDXS)'s gross revenue, earnings per share (EPS) and valuation.

Summary

Cybin beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and Cybin (OTCMKTS:CLXPF) are both health technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for (TNGN) and Cybin, as provided by MarketBeat.

Profitability

This table compares (TNGN) and Cybin's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares (TNGN) and Cybin's gross revenue, earnings per share (EPS) and valuation.

Summary

Cybin beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Abattis Bioceuticals (OTCMKTS:ATTBF) and Cybin (OTCMKTS:CLXPF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for Abattis Bioceuticals and Cybin, as provided by MarketBeat.

Profitability

This table compares Abattis Bioceuticals and Cybin's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Abattis Bioceuticals and Cybin's gross revenue, earnings per share (EPS) and valuation.

Summary

Cybin beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) and Cybin (OTCMKTS:CLXPF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for Achilles Therapeutics plc American Depositary Shares and Cybin, as provided by MarketBeat.

Profitability

This table compares Achilles Therapeutics plc American Depositary Shares and Cybin's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Achilles Therapeutics plc American Depositary Shares and Cybin's gross revenue, earnings per share (EPS) and valuation.

Summary

Cybin beats Achilles Therapeutics plc American Depositary Shares on 1 of the 1 factors compared between the two stocks.

ADiTx Therapeutics (NASDAQ:ADTX) and Cybin (OTCMKTS:CLXPF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for ADiTx Therapeutics and Cybin, as provided by MarketBeat.

Profitability

This table compares ADiTx Therapeutics and Cybin's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares ADiTx Therapeutics and Cybin's gross revenue, earnings per share (EPS) and valuation.

Summary

Cybin beats ADiTx Therapeutics on 1 of the 1 factors compared between the two stocks.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and Cybin (OTCMKTS:CLXPF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for Algernon Pharmaceuticals and Cybin, as provided by MarketBeat.

Profitability

This table compares Algernon Pharmaceuticals and Cybin's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Algernon Pharmaceuticals and Cybin's gross revenue, earnings per share (EPS) and valuation.

Summary

Cybin beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.